These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 10439038
21. Highly specific tumor binding of a 213Bi-labeled monoclonal antibody against mutant E-cadherin suggests its usefulness for locoregional alpha-radioimmunotherapy of diffuse-type gastric cancer. Senekowitsch-Schmidtke R, Schuhmacher C, Becker KF, Nikula TK, Seidl C, Becker I, Miederer M, Apostolidis C, Adam C, Huber R, Kremmer E, Fischer K, Schwaiger M. Cancer Res; 2001 Apr 01; 61(7):2804-8. PubMed ID: 11306447 [Abstract] [Full Text] [Related]
22. Dominant-negative E-cadherin alters adhesion and reverses contact inhibition of growth in breast carcinoma cells. Vizirianakis IS, Chen YQ, Kantak SS, Tsiftsoglou AS, Kramer RH. Int J Oncol; 2002 Jul 01; 21(1):135-44. PubMed ID: 12063560 [Abstract] [Full Text] [Related]
23. Alterations in classical cadherins associated with progression in ulcerative and Crohn's colitis. Jankowski JA, Bedford FK, Boulton RA, Cruickshank N, Hall C, Elder J, Allan R, Forbes A, Kim YS, Wright NA, Sanders DS. Lab Invest; 1998 Sep 01; 78(9):1155-67. PubMed ID: 9759659 [Abstract] [Full Text] [Related]
24. Extracellular cleavage and shedding of P-cadherin: a mechanism underlying the invasive behaviour of breast cancer cells. Ribeiro AS, Albergaria A, Sousa B, Correia AL, Bracke M, Seruca R, Schmitt FC, Paredes J. Oncogene; 2010 Jan 21; 29(3):392-402. PubMed ID: 19901964 [Abstract] [Full Text] [Related]
25. Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells. Miyaki M, Tanaka K, Kikuchi-Yanoshita R, Muraoka M, Konishi M, Takeichi M. Oncogene; 1995 Dec 21; 11(12):2547-52. PubMed ID: 8545111 [Abstract] [Full Text] [Related]
26. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Margulis A, Zhang W, Alt-Holland A, Crawford HC, Fusenig NE, Garlick JA. Cancer Res; 2005 Mar 01; 65(5):1783-91. PubMed ID: 15753375 [Abstract] [Full Text] [Related]
27. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling. van de Wetering M, Barker N, Harkes IC, van der Heyden M, Dijk NJ, Hollestelle A, Klijn JG, Clevers H, Schutte M. Cancer Res; 2001 Jan 01; 61(1):278-84. PubMed ID: 11196175 [Abstract] [Full Text] [Related]
28. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Ascaño JJ, Frierson H, Moskaluk CA, Harper JC, Roviello F, Jackson CE, El-Rifai W, Vindigni C, Tosi P, Powell SM. Mod Pathol; 2001 Oct 01; 14(10):942-9. PubMed ID: 11598162 [Abstract] [Full Text] [Related]
29. Enhanced cell-substratum adhesion of E-cadherin-expressing cells is mediated by activation of the small GTPase protein, Rac1. Wang Y, Ohkubo T, Tsubouchi H, Ozawa M. Int J Mol Med; 2006 Apr 01; 17(4):637-42. PubMed ID: 16525721 [Abstract] [Full Text] [Related]
30. Regulation of cell morphology and adhesion by the tuberous sclerosis complex (TSC1/2) gene products in human kidney epithelial cells through increased E-cadherin/beta-catenin activity. Li S, Braverman R, Li H, Vass WC, Lowy DR, DeClue JE. Mol Carcinog; 2003 Jun 01; 37(2):98-109. PubMed ID: 12766909 [Abstract] [Full Text] [Related]
31. Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management. Corso G, Roviello F, Paredes J, Pedrazzani C, Novais M, Correia J, Marrelli D, Cirnes L, Seruca R, Oliveira C, Suriano G. Eur J Surg Oncol; 2007 Nov 01; 33(9):1061-7. PubMed ID: 17434710 [Abstract] [Full Text] [Related]
32. Analysis of E-cadherin in diffuse-type gastric cancer using a mutation-specific monoclonal antibody. Becker KF, Kremmer E, Eulitz M, Becker I, Handschuh G, Schuhmacher C, Müller W, Gabbert HE, Ochiai A, Hirohashi S, Höfler H. Am J Pathol; 1999 Dec 01; 155(6):1803-9. PubMed ID: 10595908 [Abstract] [Full Text] [Related]
33. Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts. Karmakar S, Das C. J Reprod Immunol; 2004 Dec 01; 64(1-2):9-29. PubMed ID: 15596224 [Abstract] [Full Text] [Related]
34. E-cadherin as a tumor (invasion) suppressor gene. Birchmeier W. Bioessays; 1995 Feb 01; 17(2):97-9. PubMed ID: 7748170 [Abstract] [Full Text] [Related]
35. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. Jaggi M, Rao PS, Smith DJ, Wheelock MJ, Johnson KR, Hemstreet GP, Balaji KC. Cancer Res; 2005 Jan 15; 65(2):483-92. PubMed ID: 15695390 [Abstract] [Full Text] [Related]
36. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion. Faux MC, Ross JL, Meeker C, Johns T, Ji H, Simpson RJ, Layton MJ, Burgess AW. J Cell Sci; 2004 Jan 26; 117(Pt 3):427-39. PubMed ID: 14679305 [Abstract] [Full Text] [Related]
37. E-cadherin modulates Wnt-dependent transcription in colorectal cancer cells but does not alter Wnt-independent gene expression in fibroblasts. Kuphal F, Behrens J. Exp Cell Res; 2006 Feb 15; 312(4):457-67. PubMed ID: 16368435 [Abstract] [Full Text] [Related]
38. Molecular aspects of adhesion-epigenetic mechanisms for inactivation of the E-Cadherin-mediated cell adhesion system in cancers. Hirohashi S. Verh Dtsch Ges Pathol; 2000 Feb 15; 84():28-32. PubMed ID: 11217445 [Abstract] [Full Text] [Related]
39. Gastric cancer: new genetic developments. Lynch HT, Grady W, Suriano G, Huntsman D. J Surg Oncol; 2005 Jun 01; 90(3):114-33; discussion 133. PubMed ID: 15895459 [Abstract] [Full Text] [Related]
40. E-cadherin is required for gastrulation cell movements in zebrafish. Shimizu T, Yabe T, Muraoka O, Yonemura S, Aramaki S, Hatta K, Bae YK, Nojima H, Hibi M. Mech Dev; 2005 Jun 01; 122(6):747-63. PubMed ID: 15905076 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]